Skip to main content
SpringerLink
Log in

Harm Reduction in The Control of Infectious Diseases Among Injection Drug Users

  • Chapter
Operations Research and Health Care

Part of the book series: International Series in Operations Research & Management Science ((ISOR,volume 70))

  • 3008 Accesses

Summary

Operations research has contributed to the control of blood-borne epidemics among injection drug users. The analysis of random-mixing models has led to a deeper understanding of both syringe exchange programs and substance abuse treatment in the control of HIV/AIDS and hepatitis. This chapter presents some of these results, and analyzes illustrative models to show how simplified, but empirically pertinent mathematical models can assist policymakers evaluate public health interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Caulkins, J. and P. Reuter (1997). Setting goals for drug policy: harm reduction or use reduction? Addiction, 92, 1143–1150.

    PubMed  CAS  Google Scholar 

  2. MacCoun, R. and P. Reuter (2001). Drug War Heresies: Learning from Other Vices, Times & Places. Cambridge University Press, New York.

    Google Scholar 

  3. Des Jarlais, D., S. Friedman, and T. Ward (1993). Harm reduction: a public health response to the AIDS epidemic among injecting drug users. Annual Review of Public Health, 14, 413–450.

    PubMed  Google Scholar 

  4. Gerstein, D.R. and H.J. Harwood (1990). Treating Drug Problems. National Academy Press, Institute of Medicine, Washington, DC.

    Google Scholar 

  5. Des Jarlais, D., et al. (1995). Maintaining low HIV prevalence in populations of injecting drug users. Journal of the American Medical Association, 274, 1226–1231.

    PubMed  Google Scholar 

  6. Reuter, P., R. MacCoun, and P. Murphy (1990). Money from Crime: A Study of the Economics of Drug Dealing in Washington, DC, RAND, Santa Monica.

    Google Scholar 

  7. Kleiman, M. (1993). Against Excess: Drug Policy for Results. Basic Books, New York.

    Google Scholar 

  8. Moore, M. (2001). Toward a Balanced Drug-Prevention Strategy: A Conceptual Map, in Drug Addiction and Drug Policy, P. Heyman and W. Brownsberger, Eds., Harvard University Press, Cambridge, MA.

    Google Scholar 

  9. Saffer, H. and F. Chaloupka (1999). The demand for illicit drugs. Economic Inquiry, 37, 401–411.

    Google Scholar 

  10. Reuter, P. (2001). The need for dynamic models of drug markets. Bulletin on Narcotics, LIII, 1–10.

    Google Scholar 

  11. Caulkins, J. (1997). Mandatory Minimum Drug Sentences: Throwing Away the Key or the Taxpayers’ Money? RAND Drug Policy Research Center., Santa Monica, CA.

    Google Scholar 

  12. Burris, S., J. Welsh, M. Ng, M. Li, and A. Ditzler (2002). State syringe and drug possession laws potentially influencing safe syringe disposal by injection drug users. Journal of the American Pharmaceutical Association, 42, S94–s98.

    PubMed  Google Scholar 

  13. Caulkins, J.P., C.P. Rydell, S.S. Everingham, J. Chiesa, and S. Bushway (forthcoming). An Ounce of Prevention, a Pound of Uncertainty: The Cost-effectiveness of School-based Drug Prevention Programs. RAND Drug Policy Research Center, Santa Monica, CA.

    Google Scholar 

  14. Boyum, D. and M. Kleiman (1995). Alcohol and other drugs, in Crime, J.Q. Wilson and J. Petersilia, Eds., Institute for Contemporary Studies, San Francisco, CA.

    Google Scholar 

  15. Caulkins, J.P. and P. Reuter (1998). What price data tell us about drug markets. Journal of Drug Issues, 28, 593–612.

    Google Scholar 

  16. Caulkins, J. (1995). Domestic geographic variation in illicit drug prices. Journal of Urban Economics, 37, 38–56.

    Article  MATH  Google Scholar 

  17. Bach, P. and J. Lantos (1999). Methadone dosing, heroin affordability, and the severity of addiction. American Journal of Public Health, 89, 662–665.

    PubMed  CAS  Google Scholar 

  18. Becker, G. and K. Murphy (1988). A theory of rational addiction. Journal of Political Economy, 96, 675–700.

    Google Scholar 

  19. Caulkins, J. (2001). The dynamic character of drug problems. Bulletin on Narcotics, LIII, 11–23.

    Google Scholar 

  20. Rossi, C. (2001). A mover-stayer type model for epidemics of problematic drug use. Bulletin on Narcotics, LIII, 39–64.

    Google Scholar 

  21. Heymann, P. and W. Brownsberger, Eds. (2001). Drug Addiction and Drug Policy: The Struggle to Control Dependence. Harvard University Press, Cambridge, MA.

    Google Scholar 

  22. Hubbard, R.L. (1989). Drug Abuse Treatment: A National Study of Effectiveness. University of North Carolina Press, Chapel Hill, NC.

    Google Scholar 

  23. Massing, M. (1998). The Fix. Simon and Schuster, New York, NY.

    Google Scholar 

  24. D’Aunno, T. and H. Pollack (2002). Changes in methadone treatment practices: Results from a national panel study, 1988–2000. Journal of the American Medical Association, 288, 850–856.

    PubMed  Google Scholar 

  25. Ball, J.C. and A. Ross (1991). The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services, and Outcomes. Springer-Verlag, New York, NY.

    Google Scholar 

  26. Gunne, L. and L. Gronbladh (1981). The Swedish methadone maintenance program: a controlled study. Drug and Alcohol Dependence, 7, 249–256.

    Article  PubMed  CAS  Google Scholar 

  27. Heimer, R. (1998). Can syringe exchange serve as a conduit to substance abuse treatment? Journal of Substance Abuse Treatment, 15, 183–191.

    Article  PubMed  CAS  Google Scholar 

  28. Pollack, H. (2001). Controlling infectious diseases among injection drug users: Learning (the right) lessons from Acquired Autoimmunodeficiency Syndrome (AIDS). Bulletin on Narcotics, LIII, 91–104.

    Google Scholar 

  29. Kaplan, E. and D. Soloschatz (1993). How many drug injectors are there in New Haven? Answers from AIDS data. Mathematical and Computer Modelling, 17, 109–115.

    Article  Google Scholar 

  30. Institute of Medicine (2000). No Time to Lose: Making the Most of HIV Prevention. National Academy Press, Washington, DC.

    Google Scholar 

  31. Kaplan, E. and R. Heimer (1992). A model-based estimate of HIV infectivity via needle sharing. Journal of AIDS, 5, 1116–1118.

    CAS  Google Scholar 

  32. Metzger, D., Navaline H, and W. GE (1998). Drug abuse treatment as AIDS prevention. Public Health Reports, 113, 97–106.

    PubMed  Google Scholar 

  33. Langendam, M., G. van Brussel, R. Coutinho, and E. van Ameijden (1999). Methadone maintenance treatment modalities in relation to incidence of HIV: results of the Amsterdam cohort study. AIDS, 13, 1711–1716.

    Article  PubMed  CAS  Google Scholar 

  34. Langendam, M., G. van Brussel, R. Coutinho, and E. van Ameijden (2000). Methadone maintenance and cessation of injecting drug use: results from the Amsterdam Cohort Study. Addiction, 95, 591–600.

    Article  PubMed  CAS  Google Scholar 

  35. Metzger, D., et al. (1993). Human immunodeficiency virus seroconversion among intravenous drug users in-and out-of-treatment: An 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 6, 1049–1056.

    CAS  Google Scholar 

  36. Battjes, R., R. Pickens, and L. Brown (1995). HIV infection and AIDS risk behaviors among injection drug users entering methadone treatment: An update. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 10, 90–96.

    PubMed  CAS  Google Scholar 

  37. McCoy, C., L. Metsch, D. Chitwood, P. Shapshak, and S. Comerford (1998). Parenteral transmission of HIV among injection drug users: Assessing the frequency of multiperson use of needles, syringes, cookers, cotton, and water. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, S25–S29.

    PubMed  Google Scholar 

  38. Alter, M. and L. Moyer (1998). The importance of preventing Hepatitis C virus infection among injection drug users in the United States. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, S6–S10.

    PubMed  Google Scholar 

  39. Short, L. and D. Bell (1993). Risk of occupational infection with blood-borne pathogens in operating and delivery room settings. American Journal of Infection Control, 21, 343–350.

    Article  PubMed  CAS  Google Scholar 

  40. Pollack, H. and R. Heimer (forthcoming). Impact and cost-effectiveness of methadone maintenance treatment in preventing HIV and hepatitis C, in Impact and Costs of Hepatitis C in Injecting Drug Users in the European Union, EMCDDA, Ed., European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal.

    Google Scholar 

  41. Selvey, L., M. Denton, and A. Plant (1997). Incidence and prevalence of hepatitis C among clients of a Brisbane methadone clinic: Factors influencing hepatitis C serostatus. Australia and New Zealand Journal of Public Health, 21, 102–104.

    CAS  Google Scholar 

  42. Crofts, N., et al. (1994). Blood-borne virus infections among Australian injecting drug users: Implications for spread of HIV. European Journal of Epidemiology, 10, 687–694.

    Article  PubMed  CAS  Google Scholar 

  43. Crofts, N., L. Nigro, K. Oman, E. Stevenson, and J. Sherman (1997). Methadone maintenance and Hepatitis C virus infection among injecting drug users. Addiction, 92, 999–1005.

    Article  PubMed  CAS  Google Scholar 

  44. Goldberg, D., G. Allardice, J. McMenamin, and G. Codere (1998). HIV in Scotland: The challenge ahead. Scottish Medical Journal, 43, 168–172.

    PubMed  CAS  Google Scholar 

  45. Goldberg, D., S. Cameron, and J. McMenamin (2000). Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high. Community Diseases and Public Health, 1, 95–97.

    Google Scholar 

  46. Taylor, A., et al. (2000). Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990–1996: Are current harm reduction strategies working? Journal of Infection, 40, 176–183.

    Article  PubMed  CAS  Google Scholar 

  47. Broers, B., et al. (1998). Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995. AIDS, 12, 2059–2066.

    PubMed  CAS  Google Scholar 

  48. Hope, V., et al. (2001). Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working? American Journal of Public Health, 91, 38–42.

    PubMed  CAS  Google Scholar 

  49. Van Ameijden, E., J. Van den Hoek, G. Mientjes, and R. Coutinho (1993). A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. European Journal of Epidemiology, 9, 255–262.

    Article  PubMed  Google Scholar 

  50. Mansson, A., T. Moestrup, E. Nordenfelt, and A. Widell (2000). Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program. Scandinavian Journal of Infectious Diseases, 32, 253–258.

    PubMed  CAS  Google Scholar 

  51. Institute of Medicine (1995). Preventing HIV Transmission: The Role of Sterile Needles and Bleach. Institute of Medicine, National Academy Press, Washington, DC.

    Google Scholar 

  52. Hagan, H., et al. (1999). Syringe exchange and risk of infection from hepatitis B and C viruses. American Journal of Epidemiology, 149, 203–213.

    PubMed  CAS  Google Scholar 

  53. Pollack, H. (2001). Cost-effectiveness of harm reduction in preventing hepatitis C among injection drug users. Medical Decision Making, 21, 357–367.

    Article  PubMed  CAS  Google Scholar 

  54. Pollack, H. (2001). Ignoring ‘downstream infection’ in the evaluation of harm reduction interventions for injection drug users. European Journal of Epidemiology, 17, 391–395.

    Article  PubMed  CAS  Google Scholar 

  55. Kaplan, E. (1995). A circulation theory of needle exchange. Operations Research, 43, 558–569.

    Google Scholar 

  56. Kaplan, E., P. Cramton, and A. Paltiel (1989). Nonrandom mixing models of HIV transmission, in Lecture Notes in Biomathematics, C. Castillo-Chavez, Ed., Springer-Verlag, New York, NY.

    Google Scholar 

  57. Zaric, G.S., M.L. Brandeau, and P.G. Barnett (2000). Methadone maintenance and HIV prevention: A cost-effectiveness analysis. American Journal of Public Health, 90, 1100–1111.

    PubMed  CAS  Google Scholar 

  58. Morris, M. (1997). Social networks and HIV. AIDS, 11, S209–s216.

    Article  PubMed  Google Scholar 

  59. Kretzschmar, M. and L. Wiessing (1998). Modelling the spread of HIV in social networks of injecting drug users. AIDS, 12, 801–811.

    Article  PubMed  CAS  Google Scholar 

  60. Caulkins, J., E. Kaplan, P. Lurie, P. O’Connor, and S.-H. Ahn (1998). Can difficult-to-reuse syringes slow the spread of HIV among injection drug users? Interfaces, 28, 23–33.

    Google Scholar 

  61. Kaplan, E.H. and H.A. Pollack (1998). Allocating HIV prevention resources. Socio-Economic Planning Sciences, 32, 257–263.

    Article  Google Scholar 

  62. Altman, D., R. Greene, and H. Sapolsky (1981). Health Planning and Regulation: The Decision-making Process. AUPHA Press, Ann Arbor, MI.

    Google Scholar 

  63. Downes, T. and T. Pogue (2002). How best to hand out money: Issues in the design and structure of intergovernmental aid formulas. Journal of Official Statistics, 18, 329–352.

    Google Scholar 

  64. Brandeau, M. (2002). Difficult choices, urgent needs: Optimal investment in HIV prevention programs, in Quantitative Evaluation of HIV Prevention Programs, E. Kaplan and R. Brookmeyer, Eds., Yale University Press, New Haven, CT.

    Google Scholar 

  65. Paltiel, A. and A. Stinnett (1998). Resource allocation and the funding of HIV prevention, in Handbook of Economic Evaluation of HIV Prevention Programs, D. Holtgrave, Ed., Plenum Press, New York, NY.

    Google Scholar 

  66. Choi, K. and T. Coates (1994). Prevention of HIV infection. AIDS, 8, 1371–1389.

    PubMed  CAS  Google Scholar 

  67. Holtgrave, D.R., Ed. (1998). Handbook of HIV Prevention Policy Analysis. Plenum Press, New York, NY.

    Google Scholar 

  68. Holtgrave, D.R. and J.A. Kelly (1996). Preventing HIV/AIDS among high-risk urban women: The cost-effectiveness of a behavioral group intervention. American Journal of Public Health, 86, 1442–1445.

    PubMed  CAS  Google Scholar 

  69. Zaslavsky, A. and A. Schirm (2002). Interactions between survey estimates and federal funding formulas. Journal of Official Statistics, 18, 371–393.

    Google Scholar 

  70. Watts, D. (1999). Small Worlds: The Dynamics of Networks Between Order and Randomness. Princeton University Press, Princeton, NJ.

    Google Scholar 

  71. Garfein, R., et al. (1998). Prevalence and incidence of Hepatitis C virus infection among young injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, S11–S19.

    PubMed  Google Scholar 

  72. Holmberg, S.D. (1996). The estimated prevalence and incidence of HIV in 96 large U.S. metropolitan areas. American Journal of Public Health, 86, 642–654.

    PubMed  CAS  Google Scholar 

  73. Coutinho, R. (1998). HIV and Hepatitis C among injecting drug users: Success in preventing HIV has not been mirrored for Hepatitis C. British Medical Journal, 317, 424–425.

    PubMed  CAS  Google Scholar 

  74. Pollack, H. (2001). Can we protect drug users from Hepatitis C? Journal of Policy Analysis and Management, 20, 358–364.

    PubMed  CAS  Google Scholar 

  75. Zaric, G.S., P.G. Barnett, and M.L. Brandeau (2000). HIV transmission and the cost-effectiveness of methadone maintenance. Management Science, 46, 1013–1031.

    Article  Google Scholar 

  76. Anderson, R.M. and R.M. May (1991). Infectious Diseases of Humans. Oxford University Press, Oxford.

    Google Scholar 

  77. Kaplan, E.H. (1989). Needles that kill: Modeling human Immuno-deficiency virus transmission via shared needle injection equipment in shooting galleries. Reviews of Infectious Diseases, 11, 289–298.

    PubMed  CAS  Google Scholar 

  78. Vlahov, D., et al. (1995). Incidence and risk factors for human T-lymphotropic virus type II seroconversion among injecting drug users in Baltimore, Maryland, U.S.A. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 9, 89–96.

    CAS  Google Scholar 

  79. Stark, K., R. Muller, U. Bienzle, and I. Guggenmoos-Holzmann (1996). Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin. AIDS, 10, 311–317.

    PubMed  CAS  Google Scholar 

  80. Shah, S., et al. (1996). Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: A preliminary laboratory report. Journal of Acquired Immune Deficiency Syndromes, 11, 301–306.

    CAS  Google Scholar 

  81. Koester, S., R. Booth, and W. Wiebel (1990). The risk of HIV transmission from sharing water, drug mixing containers and cotton filters among intravenous drug users. International Journal of Drug Policy, 1, 28–30.

    Google Scholar 

  82. Koester, S., R. Booth, and E. Zhang (1996). The prevalence of additional injection-relation HIV risk behaviors among injection drug users. Journal of Acquired Immunodeficiency Syndrome and Human Retrovirology, 12, 202–207.

    CAS  Google Scholar 

  83. Hagan, H., et al. (2001). Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health, 91, 42–46.

    PubMed  CAS  Google Scholar 

  84. Grund, J., C. Kaplan, N. Adriaans, and P. Blanken (1991). Drug sharing and HIV transmission risks: The practice of frontloading in the Dutch injecting drug user population. Journal of Psychoactive Drugs, 23, 1–10.

    PubMed  CAS  Google Scholar 

  85. Kaplan, E. and Y. Lee (1990). How bad can it get? Bounding worst case endemic heterogeneous mixing models of HIV/AIDS. Mathematical Biosciences, 99, 157–180.

    Article  PubMed  MathSciNet  CAS  Google Scholar 

  86. Des Jarlais, D., et al. (1999). Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: A quasirandomised trial. Lancet, 353, 1657–1661.

    Article  PubMed  Google Scholar 

  87. Velasco-Hernandez, J., H. Gershengorn, and S. Blower (2002). Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? Lancet Infectious Diseases, 2, 487–493.

    PubMed  CAS  Google Scholar 

  88. Pollack, H. (2002). Methadone treatment as HIV prevention: Cost-effectiveness analysis, in Quantitative Evaluation of HIV Prevention Programs, E.H. Kaplan and R. Brookmeyer, Eds., Yale University Press, New Haven, CT.

    Google Scholar 

  89. Holtgrave, D. and S. Pinkerton (1997). Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 16, 54–62.

    CAS  Google Scholar 

  90. Hirth, R., M. Chernew, E. Miller, A. Fendrick, and W. Weissert (2000). Willingness to pay for a quality-adjusted life year: In search of a standard. Medical Decision Making, 20, 332–342.

    PubMed  CAS  Google Scholar 

  91. Brown, K. and N. Crofts (1998). Health care costs of a continuing epidemic of Hepatitis C virus infection among injecting drug users. Australian and New Zealand Journal of Public Health, 22, 384–388.

    PubMed  CAS  Google Scholar 

  92. Wong, J.B., W.G. Bennett, R.S. Koff, and S.G. Pauker (1998). Pretreatment evaluation of chronic Hepatitis C: Risks, benefits, and costs. Journal of the American Medical Association, 280, 2088–2093.

    Article  PubMed  CAS  Google Scholar 

  93. Kaplan, E. and R. Heimer (1994). A circulation theory of needle exchange. AIDS, 8, 567–574.

    PubMed  CAS  Google Scholar 

  94. Tengs, T., et al. (1995). Five-hundred life-saving interventions and their cost-effectiveness. Risk Analysis, 15, 369–390.

    PubMed  CAS  Google Scholar 

  95. Strang, J., P. Griffiths, B. Powis, J. Abbey, and M. Gossop (1997). How constant is an individual’s route of heroin administration? Data from treatment and non-treatment samples. Drug and Alcohol Dependence, 46, 115–118.

    Article  PubMed  CAS  Google Scholar 

  96. Blower, S., A. Aschenbach, and J. Kahn (2003). Predicting the transmission of drug-resistant HIV: Comparing theory with data. Lancet Infectious Diseases, 3, 10–11.

    Article  PubMed  Google Scholar 

  97. Cohen, C. (1999). Boundaries of Blackness: AIDS and the Breakdown of Black Politics. University of Chicago Press, Chicago, IL.

    Google Scholar 

  98. Lurie, P. and E. Drucker (1997). An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. Lancet, 349, 604–608.

    PubMed  CAS  Google Scholar 

  99. Freud, S. (1928). Future of an Illusion. W. W. Norton, New York, NY.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Public Health, University of Michigan Ann Arbor, MI, 48109

    Harold Pollack

Authors
  1. Harold Pollack
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Stanford University, USA

    Margaret L. Brandeau

  2. Georgia Institute of Technology, USA

    François Sainfort

  3. University of California at Los Angeles, USA

    William P. Pierskalla

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science + Business Media, Inc.

About this chapter

Cite this chapter

Pollack, H. (2005). Harm Reduction in The Control of Infectious Diseases Among Injection Drug Users. In: Brandeau, M.L., Sainfort, F., Pierskalla, W.P. (eds) Operations Research and Health Care. International Series in Operations Research & Management Science, vol 70. Springer, Boston, MA. https://doi.org/10.1007/1-4020-8066-2_14

Download citation

  • DOI: https://doi.org/10.1007/1-4020-8066-2_14

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4020-7629-9

  • Online ISBN: 978-1-4020-8066-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation